Funds · 13F filer · New York, NY

Rubric Capital Management LP

$10.9B in 86 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+47.4%S&P 500 +20.9%
3y return+112.0%S&P 500 +68.5%
5y return+95.7%S&P 500 +74.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since December 31, 2016: $319 against $334 in the S&P 500.2

Rubric Capital Management LPS&P 500 (SPY)
$78$100$33420162026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
TLNTalen Energy Corp$1.4B12.7%
Ftai Aviation LtdCUSIP G3730V105$811.6M7.4%+16.5%
VTRSViatris Inc$542.6M5.0%+2.0%
Teva Pharmaceutical Inds LtdCUSIP 881624209$527.7M4.8%+2.1%
Golar Lng LtdCUSIP G9456A100$457.5M4.2%
VSTVistra Corp$284.7M2.6%+19.7%
TACTransalta Corp$279.8M2.6%+13.8%
FLRFluor Corp$262.9M2.4%New
Kiniksa Pharmaceuticals IntlCUSIP G52694109$255.8M2.3%+6.7%
BGCBgc Group Inc$254.4M2.3%+2.1%
ZMZoom Communications Inc$238.7M2.2%+176.3%
GILGildan Activewear Inc$232.2M2.1%+222.4%
ARQTArcutis Biotherapeutics Inc$216.9M2.0%
AMZNAmazon Com Inc$214.5M2.0%New
Roivant Sciences LtdCUSIP G76279101$212.3M1.9%+20.0%
ZYMEZymeworks Inc$183.0M1.7%
Amcor PLCCUSIP G0250X149$180.4M1.7%+227.9%
Cimpress PLCCUSIP G2143T103$178.0M1.6%+7.4%
AMRXAmneal Pharmaceuticals Inc$176.0M1.6%−7.9%
NRIXNurix Therapeutics Inc$175.3M1.6%+192.2%
MCYMercury Genl Corp New$164.3M1.5%−28.5%
PFSIPennymac Finl Svcs Inc New$148.1M1.4%+3006.3%
IARTIntegra Lifesciences Hldgs C$139.3M1.3%
DKDelek Us Hldgs Inc New$136.5M1.3%
Liberty Global LtdCUSIP G61188101$133.6M1.2%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
AMRXAmneal Pharmaceuticals IncJune 30, 2023+458.4%$176.0M
Roivant Sciences LtdCUSIP G76279101December 31, 2022+342.9%$212.3M
Teva Pharmaceutical Inds LtdCUSIP 881624209March 31, 2023+282.8%$527.7M
Golar Lng LtdCUSIP G9456A100June 30, 2021+276.2%$457.5M
Kiniksa Pharmaceuticals IntlCUSIP G52694109June 30, 2024+242.5%$255.8M
ZYMEZymeworks IncDecember 31, 2022+232.6%$183.0M
DKDelek Us Hldgs Inc NewSeptember 30, 2024+171.0%$136.5M
Ftai Aviation LtdCUSIP G3730V105March 31, 2025+143.7%$811.6M
Cimpress PLCCUSIP G2143T103June 30, 2025+116.4%$178.0M
TLNTalen Energy CorpSeptember 30, 2024+115.6%$1.4B

Sold off last quarter

  • CEGConstellation Energy Corp was $199.7M
  • AKAMAkamai Technologies Inc was $149.3M
  • TDSTelephone & Data Sys Inc was $77.9M
  • PTGXProtagonist Therapeutics Inc was $45.1M
  • Calavo Growers IncCUSIP 128246105 was $36.5M
  • TSATTelesat Corp was $30.5M
  • BMRNBiomarin Pharmaceutical Inc was $24.9M
  • INDVIndivior Pharmaceuticals Inc was $20.2M
  • ACHCAcadia Healthcare Company In was $19.9M
  • Capri Holdings LimitedCUSIP G1890L107 was $11.9M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+14.1%+14.8%
March 31, 2026+0.9%−4.6%
December 31, 2025+5.4%+2.4%
September 30, 2025+21.5%+7.8%
June 30, 2025+12.4%+10.5%
March 31, 2025−9.9%−4.6%
December 31, 2024+7.3%+2.1%
September 30, 2024+11.0%+5.4%
June 30, 2024−2.2%+4.0%
March 31, 2024+6.8%+10.0%
December 31, 2023+11.3%+11.2%
September 30, 2023+2.5%−3.6%
June 30, 2023+5.6%+8.3%
March 31, 2023+3.7%+7.0%
December 31, 2022+8.0%+7.1%
September 30, 2022−1.2%−5.3%
June 30, 2022−16.3%−16.5%
March 31, 2022−1.7%−4.9%
December 31, 2021−0.2%+10.7%
September 30, 2021−3.7%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1687509
  2. 2
    Filed August 14, 2026 · accession 0001104659-26-097098